Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Kars

Showing results (41-50 of 54) with videos related to

Pageof 6
Sort By:
Cancer Investigation|January 1, 1996
High-dose ifosfamide by infusion with Mesna in advanced refractory sarcomasI Güllü, S Yalçin, G Tekuzman, et al.
Journal of Chemotherapy (Florence, Italy)|August 1, 1996
Ifosfamide, mesna and epirubicin as second-line chemotherapy in advanced breast cancerS Kiraz, E Baltali, N Güler, et al.
Tumori|July 1, 1995
Non-Hodgkin's lymphomas of the tonsil: a retrospective analysis of twenty-eight patients with primary tonsillary lymphomaI Barişta, G Tekuzman, I Güllü, et al.
Tumori|March 1, 1997
Ifosfamide and etoposide in previously treated patients with advanced breast cancerS Kiraz, E Baltali, N Güler, et al.
Acta Oncologica (Stockholm, Sweden)|June 20, 2000
Primary breast lymphomas--a retrospective analysis of twelve casesI Barişta, E Baltali, G Tekuzman, et al.
Chemotherapy|November 1, 1995
Tumor lysis syndrome following single-dose mitoxantroneM Benekli, M C Savaş, I H Güllü, et al.
Cancer Investigation|July 29, 1998
Bolus and continuous infusion mitoxantrone in newly diagnosed adult acute lymphoblastic leukemia: results of two consecutive phase II clinical studiesY Koc, G Akpek, E Kansu, et al.
Hematology (Amsterdam, Netherlands)|July 14, 2016
Granulocyte-Colony Stimulating Factor (G-CSF) Administration for Chemotherapy-Induced NeutropeniaŞ Yalçin, N Güler, E Kansu, et al.
European Journal of Haematology|November 20, 1998
VB-CHEP chemotherapy regimen for aggressive non-Hodgkin's lymphomasS Yalçin, A Kars, Y Ozişik, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 1, 1996
Pre- and post-therapy thallium-201 and technetium-99m-sestamibi SPECT in nasopharyngeal carcinomaL Kostakoglu, U Uysal, E Ozyar, et al.
Pageof 6

Showing results (41-50 of 54) with videos related to

Sort By:
Pageof 6
Cancer Investigation|January 1, 1996
High-dose ifosfamide by infusion with Mesna in advanced refractory sarcomasI Güllü, S Yalçin, G Tekuzman, et al.
Journal of Chemotherapy (Florence, Italy)|August 1, 1996
Ifosfamide, mesna and epirubicin as second-line chemotherapy in advanced breast cancerS Kiraz, E Baltali, N Güler, et al.
Tumori|July 1, 1995
Non-Hodgkin's lymphomas of the tonsil: a retrospective analysis of twenty-eight patients with primary tonsillary lymphomaI Barişta, G Tekuzman, I Güllü, et al.
Tumori|March 1, 1997
Ifosfamide and etoposide in previously treated patients with advanced breast cancerS Kiraz, E Baltali, N Güler, et al.
Acta Oncologica (Stockholm, Sweden)|June 20, 2000
Primary breast lymphomas--a retrospective analysis of twelve casesI Barişta, E Baltali, G Tekuzman, et al.
Chemotherapy|November 1, 1995
Tumor lysis syndrome following single-dose mitoxantroneM Benekli, M C Savaş, I H Güllü, et al.
Cancer Investigation|July 29, 1998
Bolus and continuous infusion mitoxantrone in newly diagnosed adult acute lymphoblastic leukemia: results of two consecutive phase II clinical studiesY Koc, G Akpek, E Kansu, et al.
Hematology (Amsterdam, Netherlands)|July 14, 2016
Granulocyte-Colony Stimulating Factor (G-CSF) Administration for Chemotherapy-Induced NeutropeniaŞ Yalçin, N Güler, E Kansu, et al.
European Journal of Haematology|November 20, 1998
VB-CHEP chemotherapy regimen for aggressive non-Hodgkin's lymphomasS Yalçin, A Kars, Y Ozişik, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 1, 1996
Pre- and post-therapy thallium-201 and technetium-99m-sestamibi SPECT in nasopharyngeal carcinomaL Kostakoglu, U Uysal, E Ozyar, et al.
Pageof 6